And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs ...

On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...

With shrinking farmland due to urban expansion and the declining performance of traditional seeds, scientists and growers ...

A major fire broke out at a biotechnology company in northern China, sending towering flames and thick smoke around a ...

Norgine, a leading European specialty pharmaceutical company, today announced an exclusive licensing agreement under which ...

Cathie Wood’s ARK Investment Management sharply increased its exposure to AI-driven biotechnology and cryptocurrency during ...

MAIA Biotechnology (MAIA) announced that independent directors including Adelina Louie Ngar Yee and Stan Smith, purchased common stock and ...

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

It took 27 years, but Cytokinetics secured its first U.S. drug approval. On Friday, the Food and Drug Administration cleared ...

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

If there’s one phrase it would be impossible to escape in the news this year, it’s artificial intelligence, and Pennsylvania ...

TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA(1) positive operations in Q3 2025 and expects to achieve strong ...